Hollencrest Capital Management Bristol Myers Squibb CO Transaction History

Hollencrest Capital Management

  • $2.36 Billion
  • Q3 2024

A detailed history of Hollencrest Capital Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hollencrest Capital Management holds 492 shares of BMY stock, worth $28,378. This represents 0.0% of its overall portfolio holdings.

Number of Shares
492
Previous 305 61.31%
Holding current value
$28,378
Previous $12,000 108.33%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
BUY
$39.66 - $51.75 $7,416 - $9,677
187 Added 61.31%
492 $25,000
Q4 2023

Feb 14, 2024
SELL
$48.48 - $57.85 $1,163 - $1,388
-24 Reduced 7.29%
305 $15,000
Q2 2023

Aug 10, 2023
SELL
$63.71 - $70.74 $47,782 - $53,054
-750 Reduced 69.51%
329 $21,000
Q1 2023

May 16, 2023
SELL
$65.71 - $74.53 $2,299 - $2,608
-35 Reduced 3.14%
1,079 $74,000
Q4 2022

Feb 06, 2023
SELL
$68.48 - $81.09 $1.14 Million - $1.36 Million
-16,715 Reduced 93.75%
1,114 $80,000
Q3 2022

Oct 27, 2022
SELL
$0.13 - $76.84 $100 - $59,166
-770 Reduced 4.14%
17,829 $1.27 Million
Q2 2022

Jul 21, 2022
BUY
$72.62 - $79.98 $21,786 - $23,994
300 Added 1.64%
18,599 $1.43 Million
Q4 2021

Jan 07, 2022
BUY
$53.63 - $62.52 $26,815 - $31,260
500 Added 2.81%
18,299 $1.14 Million
Q1 2021

Apr 29, 2021
BUY
$59.34 - $66.74 $243,294 - $273,634
4,100 Added 29.93%
17,799 $1.12 Million
Q4 2020

Jan 26, 2021
BUY
$57.74 - $65.43 $115,710 - $131,121
2,004 Added 17.14%
13,699 $850,000
Q2 2020

Jul 16, 2020
BUY
$54.82 - $64.09 $641,119 - $749,532
11,695 New
11,695 $688,000
Q3 2019

Oct 23, 2019
SELL
$42.77 - $50.71 $599,164 - $710,396
-14,009 Closed
0 $0
Q2 2019

Jul 18, 2019
SELL
$44.62 - $49.34 $89,150 - $98,581
-1,998 Reduced 12.48%
14,009 $635,000
Q4 2018

May 09, 2019
BUY
$48.76 - $63.23 $312,210 - $404,861
6,403 Added 66.67%
16,007 $832,000
Q4 2018

Jan 03, 2019
SELL
$48.76 - $63.23 $312,210 - $404,861
-6,403 Reduced 40.0%
9,604 $499,000
Q3 2018

May 09, 2019
BUY
$55.19 - $62.25 $691,475 - $779,930
12,529 Added 360.24%
16,007 $763,000
Q3 2018

Oct 04, 2018
BUY
$55.19 - $62.25 $191,950 - $216,505
3,478 New
3,478 $216,000
Q2 2018

Jul 10, 2018
SELL
$50.53 - $62.98 $523,137 - $652,031
-10,353 Closed
0 $0
Q1 2018

Apr 24, 2018
BUY
$59.92 - $68.98 $77,896 - $89,674
1,300 Added 14.36%
10,353 $655,000
Q4 2017

Jan 19, 2018
BUY
$59.94 - $65.35 $89,910 - $98,024
1,500 Added 19.86%
9,053 $0
Q3 2017

Oct 10, 2017
BUY
$55.23 - $63.74 $417,152 - $481,428
7,553
7,553 $481,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hollencrest Capital Management Portfolio

Follow Hollencrest Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email